Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

EVIDENCE FOR A CRITICAL PERIOD FOR POSTNATAL ELEVATION OF BRAIN TYROSINE HYDROXYLASE ACTIVITY RESULTING FROM RESERPINE ADMINISTRATION DURING EMBRYONIC DEVELOPMENT

R. B. Lydiard and S. B. Sparber
Journal of Pharmacology and Experimental Therapeutics May 1974, 189 (2) 370-379;
R. B. Lydiard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. B. Sparber
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Previous work in our laboratory has shown that injection of reserpine into the yolk sac of fertilized, unincubated chicken eggs resulted in decreased whole brain catecholamines at 14 days of embryonic development while at 30 days after hatching catecholamines were significantly elevated. The possible involvement of tyrosine hydroxylase (TH) in these observations was studied. At 10 days of development, brain TH activity in reserpinetreated embryos was not significantly different from vehicle-injected or uninjected controls, although catecholamines were significantly reduced. By 15 days of embryonic development, TH activity increased 4-fold and reserpine treatment caused a significant increase in enzyme activity over controls. By 20 days of development TH activity increased an additional 8.5-fold, to about 33 times the activity at 10 days, but between this time and 29 days of age after hatching TH activity increased only an additional 40%. Most important, however, is the continued significantly elevated TH activity at 29 days of age in the reserpine-treated group, suggesting a longer lasting effect upon enzyme activity than has been shown previously. The data support the contention that nervous activity is essential for compensatory induction or activation and that a critical period for a set-point of enzymatic activity may exist during development.

Footnotes

    • Received August 28, 1972.
    • Accepted January 7, 1974.
  • © 1974 by The Williams & Wilkins Co.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 189, Issue 2
1 May 1974
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
EVIDENCE FOR A CRITICAL PERIOD FOR POSTNATAL ELEVATION OF BRAIN TYROSINE HYDROXYLASE ACTIVITY RESULTING FROM RESERPINE ADMINISTRATION DURING EMBRYONIC DEVELOPMENT
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

EVIDENCE FOR A CRITICAL PERIOD FOR POSTNATAL ELEVATION OF BRAIN TYROSINE HYDROXYLASE ACTIVITY RESULTING FROM RESERPINE ADMINISTRATION DURING EMBRYONIC DEVELOPMENT

R. B. Lydiard and S. B. Sparber
Journal of Pharmacology and Experimental Therapeutics May 1, 1974, 189 (2) 370-379;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

EVIDENCE FOR A CRITICAL PERIOD FOR POSTNATAL ELEVATION OF BRAIN TYROSINE HYDROXYLASE ACTIVITY RESULTING FROM RESERPINE ADMINISTRATION DURING EMBRYONIC DEVELOPMENT

R. B. Lydiard and S. B. Sparber
Journal of Pharmacology and Experimental Therapeutics May 1, 1974, 189 (2) 370-379;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Streptococcus pneumoniae Pneumonia in Mice: Optimal Amoxicillin Dosing Predicted from a Pharmacokinetic-Pharmacodynamic Model
  • Modulation by Drugs of Human Hepatic Sodium-Dependent Bile Acid Transporter (Sodium Taurocholate Cotransporting Polypeptide) Activity
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics